STOCK TITAN

Blend Labs Inc Financials

BLND
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Blend Labs Inc (BLND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLND FY2025

Blend's business mechanic is a cost-base reset: similar revenue now supports far smaller losses and almost no cash burn.

Across FY2023-FY2025, operating margin improved dramatically, which points to a much lighter fixed-cost structure rather than a demand surge. That accounting improvement also reached cash: operating cash flow swung from -$127.6M to $11.5M, meaning the company no longer needs the same level of outside funding just to run the core business.

The important margin story is not price; it is expense compression. With gross margin already high at 73.8%, the near-break-even result came mainly from a smaller operating cost stack, not from a sudden jump in scale. Revenue in FY2025 was only modestly above FY2023, so the earnings improvement came more from resizing the organization than from adding volume.

The balance sheet still shows negative equity, because liabilities exceed assets by about $30.5M, but long-term debt is $0, so the pressure is more about preserving liquidity than servicing lenders. A current ratio of 2.5x and cash of $43.6M provide operating room, though not enough to make cash deployment choices trivial when free cash flow is only around breakeven.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 65 / 100
Financial Health Score 65/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Blend Labs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
85
Dilution
68
R&D Intensity
55
Revenue Progress
57
Burn Trend
87
Balance Sheet
40
Altman Z-Score Distress
-9.50

Blend Labs Inc scores -9.50, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($411.6M) relative to total liabilities ($200.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Blend Labs Inc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
-1.69x

For every $1 of reported earnings, Blend Labs Inc generates $-1.69 in operating cash flow ($11.5M OCF vs -$6.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$123.6M
YoY+6.8%
5Y CAGR+5.2%

Blend Labs Inc generated $123.6M in revenue in fiscal year 2025. This represents an increase of 6.8% from the prior year.

EBITDA
-$18.4M
YoY+61.2%

Blend Labs Inc's EBITDA was -$18.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 61.2% from the prior year.

Net Income
-$6.8M
YoY+84.3%

Blend Labs Inc reported -$6.8M in net income in fiscal year 2025. This represents an increase of 84.3% from the prior year.

EPS (Diluted)
$-0.10
YoY+58.3%

Blend Labs Inc earned $-0.10 per diluted share (EPS) in fiscal year 2025. This represents an increase of 58.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$81K
YoY+99.6%

Blend Labs Inc generated -$81K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 99.6% from the prior year.

Cash & Debt
$45.1M
YoY+18.5%
5Y CAGR+1.9%

Blend Labs Inc held $45.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
256M
YoY-0.8%

Blend Labs Inc had 256M shares outstanding in fiscal year 2025. This represents a decrease of 0.8% from the prior year.

Margins & Returns

Gross Margin
73.8%
YoY+1.9pp
5Y CAGR+9.5pp

Blend Labs Inc's gross margin was 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.9 percentage points from the prior year.

Operating Margin
-17.6%
YoY+24.6pp
5Y CAGR+60.8pp

Blend Labs Inc's operating margin was -17.6% in fiscal year 2025, reflecting core business profitability. This is up 24.6 percentage points from the prior year.

Net Margin
-5.5%
YoY+31.9pp
5Y CAGR+72.2pp

Blend Labs Inc's net profit margin was -5.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 31.9 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$32.8M
YoY-28.7%
5Y CAGR-10.0%

Blend Labs Inc invested $32.8M in research and development in fiscal year 2025. This represents a decrease of 28.7% from the prior year.

Share Buybacks
$24.9M
5Y CAGR+324.7%

Blend Labs Inc spent $24.9M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$11.6M
YoY+19.0%
5Y CAGR+54.6%

Blend Labs Inc invested $11.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 19.0% from the prior year.

BLND Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $30.8M-4.9% $32.4M-0.9% $32.7M+3.4% $31.6M+17.8% $26.8M-10.9% $30.1M-9.0% $33.1M+15.4% $28.7M
Cost of Revenue $7.5M-5.1% $7.9M-6.3% $8.4M+1.7% $8.3M+5.5% $7.8M+0.8% $7.8M-9.5% $8.6M+3.0% $8.4M
Gross Profit $23.4M-4.8% $24.5M+1.1% $24.3M+3.9% $23.4M+22.9% $19.0M-14.9% $22.3M-8.8% $24.5M+20.4% $20.3M
R&D Expenses $9.4M+6.8% $8.8M+1.2% $8.7M+16.3% $7.5M-4.5% $7.8M-11.5% $8.9M-12.5% $10.1M-21.6% $12.9M
SG&A Expenses $12.2M-0.5% $12.2M-5.7% $13.0M-5.6% $13.7M+22.1% $11.2M+7.2% $10.5M-8.8% $11.5M+0.9% $11.4M
Operating Income -$5.1M-41.3% -$3.6M+33.0% -$5.3M-10.8% -$4.8M+39.5% -$8.0M-143.9% -$3.3M+71.0% -$11.3M+13.7% -$13.1M
Interest Expense N/A $0 $0 $0 $0 $0 $0-100.0% $1.6M
Income Tax $63K-58.3% $151K+459.3% $27K-34.1% $41K+36.7% $30K+87.5% $16K-23.8% $21K-30.0% $30K
Net Income -$8.0M-217.8% -$2.5M-120.9% $12.1M+276.7% -$6.8M+28.1% -$9.5M-1053.6% -$825K+66.3% -$2.4M+87.4% -$19.4M
EPS (Diluted) $-0.05 N/A $0.02+166.7% $-0.03+50.0% $-0.06 N/A $-0.03+66.7% $-0.09

BLND Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $161.3M-5.2% $170.0M-9.8% $188.6M+3.5% $182.2M-2.8% $187.5M+5.3% $178.1M-4.3% $186.1M+0.4% $185.4M
Current Assets $93.1M-6.7% $99.8M-13.7% $115.7M-8.5% $126.4M-9.4% $139.5M+3.1% $135.2M-7.6% $146.4M+2.7% $142.5M
Cash & Equivalents $37.4M-16.9% $45.1M-18.1% $55.0M+50.7% $36.5M-35.1% $56.2M+48.0% $38.0M-24.8% $50.6M+21.1% $41.8M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $217.2M+8.3% $200.5M-0.7% $202.0M-1.6% $205.2M+0.3% $204.6M-12.7% $234.4M-0.5% $235.7M+2.1% $230.9M
Current Liabilities $51.5M+30.4% $39.5M-13.6% $45.6M-12.8% $52.4M-9.1% $57.6M+47.6% $39.0M-13.8% $45.2M+9.0% $41.5M
Long-Term Debt N/A $0 $0 $0 $0 $0 $0 $0
Total Equity -$55.9M-83.5% -$30.5M-127.2% -$13.4M+41.8% -$23.1M-34.2% -$17.2M+69.5% -$56.4M-13.6% -$49.6M-9.1% -$45.5M
Retained Earnings -$1.4B-0.6% -$1.4B-0.2% -$1.4B+0.9% -$1.4B-0.5% -$1.4B-0.7% -$1.4B-0.1% -$1.4B-0.2% -$1.4B

BLND Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $7.4M+378.0% $1.5M+142.3% -$3.6M+44.0% -$6.5M-132.3% $20.1M+538.6% -$4.6M-320.9% $2.1M+131.1% -$6.7M
Capital Expenditures $1.1M-28.4% $1.6M-26.5% $2.1M-41.0% $3.6M-16.6% $4.3M+72.7% $2.5M-27.1% $3.4M+85.0% $1.9M
Free Cash Flow $6.2M+29790.5% -$21K+99.6% -$5.8M+43.0% -$10.1M-163.9% $15.8M+323.1% -$7.1M-424.4% -$1.4M+84.1% -$8.5M
Investing Cash Flow $2.9M+259.3% -$1.8M-106.6% $27.5M+357.5% -$10.7M-405.5% $3.5M+285.4% -$1.9M-116.1% $11.7M+146.8% -$25.1M
Financing Cash Flow -$17.9M-1.7% -$17.6M-183.3% -$6.2M-69.8% -$3.7M+29.5% -$5.2M+18.1% -$6.3M-49.4% -$4.2M+42.2% -$7.3M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $16.8M+7.1% $15.7M+213.0% $5.0M+224.2% $1.6M-39.6% $2.6M $0 $0 $0

BLND Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 75.8%+0.1pp 75.7%+1.4pp 74.3%+0.4pp 73.8%+3.1pp 70.8%-3.4pp 74.2%+0.2pp 74.0%+3.1pp 70.9%
Operating Margin -16.4%-5.4pp -11.1%+5.3pp -16.4%-1.1pp -15.3%+14.5pp -29.7%-18.9pp -10.9%+23.2pp -34.1%+11.5pp -45.5%
Net Margin -26.1%-18.3pp -7.8%-44.8pp 37.0%+58.7pp -21.6%+13.8pp -35.4%-32.7pp -2.7%+4.6pp -7.4%+60.2pp -67.6%
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -5.0%-3.5pp -1.5%-7.9pp 6.4%+10.2pp -3.8%+1.3pp -5.1%-4.6pp -0.5%+0.9pp -1.3%+9.2pp -10.5%
Current Ratio 1.81-0.7 2.530.0 2.53+0.1 2.410.0 2.42-1.0 3.47+0.2 3.24-0.2 3.43
Debt-to-Equity -3.88-3.9 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00
FCF Margin 20.2%+20.3pp -0.1%+17.6pp -17.6%+14.3pp -31.9%-90.8pp 58.9%+82.4pp -23.5%-19.4pp -4.1%+25.6pp -29.7%

Note: Shareholder equity is negative (-$30.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Blend Labs Inc (BLND) reported $123.6M in total revenue for fiscal year 2025. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Blend Labs Inc (BLND) revenue grew by 6.8% year-over-year, from $115.8M to $123.6M in fiscal year 2025.

No, Blend Labs Inc (BLND) reported a net income of -$6.8M in fiscal year 2025, with a net profit margin of -5.5%.

Blend Labs Inc (BLND) reported diluted earnings per share of $-0.10 for fiscal year 2025. This represents a 58.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Blend Labs Inc (BLND) had EBITDA of -$18.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Blend Labs Inc (BLND) had $45.1M in cash and equivalents against $0 in long-term debt.

Blend Labs Inc (BLND) had a gross margin of 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Blend Labs Inc (BLND) had an operating margin of -17.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Blend Labs Inc (BLND) had a net profit margin of -5.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Blend Labs Inc (BLND) generated -$81K in free cash flow during fiscal year 2025. This represents a 99.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Blend Labs Inc (BLND) generated $11.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Blend Labs Inc (BLND) had $170.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Blend Labs Inc (BLND) invested $11.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Blend Labs Inc (BLND) invested $32.8M in research and development during fiscal year 2025.

Yes, Blend Labs Inc (BLND) spent $24.9M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Blend Labs Inc (BLND) had 256M shares outstanding as of fiscal year 2025.

Blend Labs Inc (BLND) had a current ratio of 2.53 as of fiscal year 2025, which is generally considered healthy.

Blend Labs Inc (BLND) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Blend Labs Inc (BLND) had a return on assets of -4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Blend Labs Inc (BLND) has negative shareholder equity of -$30.5M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Blend Labs Inc (BLND) has an Altman Z-Score of -9.50, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Blend Labs Inc (BLND) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Blend Labs Inc (BLND) has an earnings quality ratio of -1.69x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Blend Labs Inc (BLND) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top